COVID-19 vaccine makers told Congress on Tuesday that US supplies should surge in the coming weeks due to manufacturing expansions and new vaccine authorizations.
Executives from Pfizer Inc, Moderna Inc and Johnson & Johnson – speaking at a hearing at the US House of Representatives – said they would be able to supply enough vaccine to fully inoculate 130 million people in the US by the end of March.
For more coronavirus news, visit our dedicated page.
The drugmakers also reaffirmed their commitments to supply more than enough doses necessary to vaccinate all Americans by the end of July.
Pfizer Chief Business Officer John Young said it was plausible that there could be a surplus of vaccine in the United States sometime in the second quarter of this year.
“We certainly hope that we’re going to be in a position where every eligible adult will be able to receive vaccinations,” Young said…